<DOC>
	<DOCNO>NCT01202253</DOCNO>
	<brief_summary>The purpose study describe real world effectiveness anidulafungin clinical practice large Liver Unit United Kingdom .</brief_summary>
	<brief_title>Early Clinical Experience With Anidulafungin In Patients With Liver Disease In The United Kingdom</brief_title>
	<detailed_description>All subject treat Anidulafungin accord licence period July 2009 September 2010 include .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Anidulafungin</mesh_term>
	<mesh_term>Echinocandins</mesh_term>
	<criteria>Subjects prescribe anidulafungin 1st July 2009 30th September 2010 . Patients admitted specialist liver unit ward Liver Intensive Therapy Unit period Patients participate interventional clinical trial episode sepsis . Patients receive anidulafungin infection prophylaxis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Ecalta</keyword>
	<keyword>Eraxis</keyword>
	<keyword>Candida</keyword>
	<keyword>Candidemia</keyword>
	<keyword>Systemic Candidiasis</keyword>
	<keyword>ICU</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Critical Care Unit</keyword>
</DOC>